Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy in Pulmonary Arterial Hypertension (ATHENA-1)
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Pulmonary Arterial Hypertension
Related studies linked through entity extraction aliases.
The Early Recognition of Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- NA
Pharmacogenomics in Pulmonary Arterial Hypertension
- Status
- WITHDRAWN
- Phase
- N/A
Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Long Term Study of Ambrisentan in Pulmonary Arterial Hypertension Subjects Having Completed AMB-320 (NCT00423748) or AMB-321 (NCT00423202)
- Status
- COMPLETED
- Phase
- PHASE3
Biomarkers in the Diagnosis and Assessment of Pulmonary Arterial Hypertension (PAH)
- Status
- COMPLETED
- Phase
- NA
A Study to Evaluate GSK1325760A - a Long-Term Extension Study
- Status
- COMPLETED
- Phase
- PHASE3
Rehabilitation for Patients With Pulmonary Arterial Hypertension
- Status
- UNKNOWN
- Phase
- NA
Study of Intravenous Remodulin in Patients in India With Pulmonary Arterial Hypertension
- Status
- TERMINATED
- Phase
- PHASE4
Hemodynamic Response After Six Months of Sildenafil
- Status
- UNKNOWN
- Phase
- PHASE4
Safety and Efficacy of Imatinib Mesylate in Patients With Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Safety and Efficacy of Inhaled Iloprost in Pediatric Patients With Pulmonary Arterial Hypertension
- Status
- WITHDRAWN
- Phase
- PHASE2
Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH)
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin Using the Crono Five Ambulatory Pump in Patients With PAH
- Status
- TERMINATED
- Phase
- PHASE4
6R-BH4 Pulmonary Arterial Hypertension Study
- Status
- COMPLETED
- Phase
- PHASE1
Combination Therapy in Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- PHASE4
To Assess The Efficacy and Safety Of Oral Sildenafil in the Treatment of Pulmonary Arterial Hypertension.
- Status
- TERMINATED
- Phase
- PHASE4
Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension.
- Status
- COMPLETED
- Phase
- PHASE3
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension.
- Status
- COMPLETED
- Phase
- PHASE3
Inhaled Iloprost for Sarcoidosis-associated Pulmonary Hypertension
- Status
- COMPLETED
- Phase
- PHASE4